コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d who provided at least one valid assessable serum sample.
2 s novel immunosensor was used to analyze the serum sample.
3 ination of complementary sequence in a human serum sample.
4 determination of epirubicin in a human blood serum sample.
5 ve detection of miRNAs from cell lysates and serum samples.
6 rference capability in the presence of human serum samples.
7 vant concentrations of lysozyme in undiluted serum samples.
8 x10(-21)M) both in control as well as spiked serum samples.
9 as a function of QA concentrations in human serum samples.
10 of the juvenile idiopathic arthritis in real serum samples.
11 in undiluted, immunoglobulin-deprived human serum samples.
12 e ebolavirus) variant Makona in spiked human serum samples.
13 pplied for the determination of Cys in blood serum samples.
14 re for the elimination of protein from human serum samples.
15 e similar response profile across polyclonal serum samples.
16 st with the negative results with 20 control serum samples.
17 the age range of the originator using human serum samples.
18 reover, it determined neopterin in synthetic serum samples.
19 vely analyzed with good reliability in human serum samples.
20 phenotypes has been found among 206 studied serum samples.
21 supernatants of stimulated primary cells and serum samples.
22 CR for miRNA analysis was performed using 70 serum samples.
23 samples such as drug, milk, honey and blood serum samples.
24 rgeted depletion of 5' tRNA halves in murine serum samples.
25 especially considering the complex nature of serum samples.
26 its complex with Ni(2+) by HRP-II present in serum samples.
27 aks recorded in the electropherograms of the serum samples.
28 various concentrations of standard NEFA and serum samples.
29 m model glycoproteins and pooled human blood serum samples.
30 etection limit (LOD) of 5.7 aM in real human serum samples.
31 ed successful in determining NSE in clinical serum samples.
32 glucose and cholesterol level of real human serum samples.
33 ated, together with successful validation in serum samples.
34 5846) of these proteins in individual plasma/serum samples.
35 ic antigen concentrations in patient-derived serum samples.
36 ferritin concentrations in spiked buffer and serum samples.
37 however challenging due to the complexity of serum samples.
38 detection of HER2 in complex matrix of human serum samples.
43 amount of IgG3-H435 relative to IgG-R435 in serum samples and (ii) the proportion of malaria-specifi
44 F-MS-based glycomic procedures to 20 control serum samples and 42 samples provided by patients diagno
45 applied to a convenience set of 96 unexposed serum samples and a blinded set of 80 samples treated wi
50 of 25OHD, selecting 1666 cohort members with serum samples and ensuring representation in the subcoho
51 omatography in end-of-feeding-period fasting serum samples and expressed in both relative and absolut
52 for oxytocin determination in both synthetic serum samples and in aqueous solutions was similar and,
53 and 139 stage I-III CRC patients, as well as serum samples and matched primary and metastatic liver t
54 n of the immunosensor for CA125 detection in serum samples and measuring of ovarian-cancer cells was
55 ification of p53 protein in the human spiked serum samples and more importantly in the human normal a
56 mbryonic cell culture, beverages, urine, and serum samples and reused upto 200-times within a period
57 nsor was used to detect sialic acid in blood serum samples and the results were in good agreement wit
59 ctivation products C3a, C4a and C5a in these serum samples, and found that serum levels of C3a and C5
60 reviously been reported in 22% to 100% of BP serum samples, and the pathogenic relevance of anti-BP18
61 O2 detection in the disinfected fetal bovine serum samples, and the recovery was obtained about 98%.
62 ide concentrations in maternal mid-pregnancy serum samples: association with autism spectrum disorder
65 protocol deviations, and provided evaluable serum samples at day 1 and the scheduled timepoints thro
67 immune evasion in nonhuman primate and human serum samples at dilution factors as high as 1:5, curren
68 assessed in concurrently obtained urine and serum samples at the 24-month or last on-treatment visit
70 equency questionnaire and provided a fasting serum sample before study randomization (1985-1988).
73 lpha, in gingival crevicular fluid (GCF) and serum samples between women with preterm birth (PTB) and
76 able for concentration ranges encountered in serum samples by adjusting the Fe3O4@GO Concentration.
78 nzyme-linked immunosorbent assays in GCF and serum samples collected 24 to 48 hours after labor from
80 erved peripheral blood mononuclear cells and serum samples collected at baseline, at 1- and 2-year tr
81 d next-generation sequencing on microRNAs in serum samples collected before injury and then at 1, 3,
82 s were also observed in approximately 56% of serum samples collected during 1970-1999 (20% IgG, 19% I
83 ers of meat consumption was undertaken using serum samples collected from combining high resolution m
86 region of birth in Finland, date of maternal serum sample collection, date of mother's birth, and dat
88 the IgG proteolytic activity and that piglet serum samples contain specific antibodies against IgdE s
90 st time, the present study demonstrated that serum sample denaturation decreases the test specificity
91 using purified protein solution and clinical serum samples depict high sensitivity, specificity and w
94 e-stranded RNA in bronchoalveolar lavage and serum samples following lung contusion was measured.
95 bioprobe can be employed for QA detection in serum sample for the early detection of many diseases.
96 PANSS, ACE-III, GAF) at baseline, and tested serum samples for antibodies against NMDAR, LGI1, CASPR2
97 h in which a redox mediator is used to probe serum samples for chemical information relevant to oxida
99 ctivity of alpha amylase enzyme in urine and serum samples for early diagnosis of Pancreatitis diseas
100 ersion between baseline and post-vaccination serum samples for measles, rubella, and yellow fever; an
101 ok an affinity proteomic approach to profile serum samples for proteins that could serve as indicator
102 detection of anti-PCV3 capsid antibodies in serum samples found that 46 (55%) of 83 samples tested w
103 innish Maternity Cohort and had an available serum sample from the pregnancy with the affected child.
104 hy-mass spectrometry, we measured 25(OH)D in serum samples from 1,611 women who later developed breas
106 dy to determine circulating mtDNA content in serum samples from 116 HBV-related HCC cases and 232 fre
108 pseudomallei The ELISAs were evaluated using serum samples from 141 culture-confirmed melioidosis pat
109 d Methods Ten genes were tested in duplicate serum samples from 141 women at baseline, at week 4, and
110 report eight coding-complete genomes from US serum samples from 1978-1979-eight of the nine oldest HI
120 PTX3 expression was assessed in tissue and serum samples from 54 patients with alcoholic hepatitis.
122 performed microRNA (miRNA) profiling in 318 serum samples from 69 liver transplant recipients enroll
123 kage is illustrated with a data set of blood serum samples from 7 diet induced obese (DIO) and 7 nono
124 the Finnish Maternity Cohort, a cohort with serum samples from 98% of pregnancies registered in Finl
127 achieve our objective, we assessed miRNAs in serum samples from AD patients and Mild cognitive impair
132 y available anti-BHV-1 antiserum and in real serum samples from cattle with results being in excellen
134 y acquired DENV antibodies was determined in serum samples from children enrolled in the cohort.
135 y human IgE binding by inhibition ELISA with serum samples from children with clinical allergic sympt
138 o discriminate the JIA positive and negative serum samples from different individuals using different
139 iomarkers we performed proteome profiling of serum samples from DMD and IBD patients with and without
144 nward-flow immunoassay, we tested 200 stored serum samples from high-risk patients enrolled in a long
145 nti-HIV Ab effector activities in polyclonal serum samples from HIV-infected donors, VAX004 vaccine r
148 dy of de-identified residual diagnostic test serum samples from males aged 15-39 years from laborator
150 ns naturally infected with DENV2 or DENV3 in serum samples from Nicaragua collected at acute, convale
155 ytokine enzyme-linked immunosorbent assay of serum samples from patients with acute and chronic hepat
157 of IFNgamma and TNF-alpha were increased in serum samples from patients with acute vs chronic hepati
159 We profiled ACAAs in a diverse cohort of serum samples from patients with immunodeficiency and as
160 s built and applied to an independent set of serum samples from patients with OA (n = 188), control i
161 spension bead arrays were applied to analyze serum samples from patients with OA (n = 273), control s
162 ectively measure specific antibody levels in serum samples from patients with varied infectious or au
163 zing antibody responses, convalescence-phase serum samples from people previously exposed to primary
166 using the 4,000-plex SOMAscan assay on 1,470 serum samples from seven countries where TB is endemic.
168 tested our newly developed method on serial serum samples from severe TBI (sTBI) patients (n = 72) a
170 dy, we investigate 20,152 general-population serum samples from southern Vietnam collected between 20
173 sensitivities of 77%, 45%, and 9% in bovine serum samples from the United Kingdom (n = 126), the Uni
179 ethod for non-HDL-P quantification in native serum samples implies daily calculation of the electrosp
180 er transforms infrared spectroscopy of dried serum samples in an effort to assess biochemical changes
181 nt titer distributions and the proportion of serum samples in each, from which estimates of PEF were
182 sensor was able to quantify cocaine in blood serum samples in the range of concentrations between 1nM
183 ificity and excellent recovery for the human serum samples, indicating its promising potential in bio
185 At the conclusion of the feeding protocol, serums samples, livers or isolated neutrophils were util
186 A total of 29 miRNAs were quantified in serum samples (n = 300) using a nested case-control stud
189 rmed nasopharyngeal or nasal swabbing and/or serum sampling (n = 148) in Lancaster, UK, over the wint
190 n = 142), and (2) longitudinal with repeated serum sampling (n = 246, median follow-up = 3.1 years, i
192 nsion cohorts at the same study site who had serum samples obtained at multiple early timepoints.
193 cid analysis of aqueous humour, vitreous and serum samples obtained during surgery from a 24 year old
195 Paired human hair, fingernail, toenail, and serum samples obtained from 50 adult participants recrui
196 d pellets (WBP), 583 plasma samples, and 419 serum samples obtained from hematology patients accordin
197 performed with analysis of the PSA levels in serum samples obtained from patients with prostate cance
199 sor for the assessment of 3-Nty in different serum samples of (MHE) in patients with liver cirrhosis.
208 nd/or 91 mutant HCV quasispecies in baseline serum samples of chronic HCV patients from the HALT-C tr
211 identified a serum miRNA signature in human serum samples of mild to severe TBI, which can be used f
216 in the retinas of diabetic mice (3-fold) and serum samples of patients with diabetic macular edema (1
217 c profiling of N-glycans released from blood serum samples of patients with different esophageal dise
218 sine (PLL) film was developed and applied to serum samples of prostate cancer positive for Gleason sc
219 d samples of the "usually" consumed milk and serum samples of the children were collected at age 4 ye
220 ated by the weekly testing of sow and piglet serum samples on a SVA VP1 recombinant protein (rVP1) in
222 s of 150-250 IU/mL; using nondenaturation of serum samples, our HCV-Ags EIA reliably differentiated V
223 ive sensor prototypes were tested in a human serum sample over one week and the maximum deviation of
224 from the ironPhone for the buffer and spiked serum samples provided a calibration curve with R(2) val
227 A metallomic profile of 110 CSF and 530 serum samples showed significant variations in 10 elemen
229 ion of circulating microRNAs (miRNA, miR) in serum samples specific to patients with very high-risk (
230 s of aqueous and organic extracts from human serum samples, spectral features were assigned to a tota
231 Community Respiratory Health Survey provided serum samples, spirometry, and questionnaire data about
232 he SALDI-MS results obtained on the desalted serum sample spots show both good reproducibility and co
234 an 0.7 pmol/g lw) but was below detection in serum samples, suggesting low or no bioavailability for
237 pecificity, 84%) to reduce the proportion of serum samples that were required by the more cumbersome
238 undiluted human serum as well as artificial serum sample, the slope of the linear calibration at the
239 d FTO electrode for determining ACh level in serum samples, the applicability of biosensor has increa
240 posed biosensor was introduced to real human serum samples to determine HSP70 sensitively and accurat
241 ions of DENV-reactive antibodies from immune serum samples to estimate the contribution of serotype-c
242 the current study we analyzed depleted human serum samples to evaluate experimental factors that may
244 power of COLMARm is demonstrated for a human serum sample uncovering the existence of 14 metabolites
245 tis B surface antigen (anti-HBs) in clinical serum samples using surface plasmon resonance (SPR).
246 ity, a diagnosis that was validated when her serum sample was found to contain antibodies to S-arrest
248 nce of anti-Pneumocystis antibodies in human serum samples was detected by ELISA and Western blotting
249 neous detection of CA125 and CA15-3 in human serum samples was evaluated and the obtained results wer
250 sensor for analysis of lactate in artificial serum samples was evaluated with good satisfactory resul
251 or in common interferents and clinical human serum samples was investigated, showing comparable to EL
253 this assay to recipient post-HCT plasma and serum samples, we demonstrated reactivation of HHV-6B in
256 (BAL) and lung tissue, and total free IgE in serum samples were analyzed 24, 48, and 96 hours after t
258 -14 weeks) and third-trimester (30-34 weeks) serum samples were analyzed using targeted metabolomic (
261 imaging and other methods; tumor, liver, and serum samples were collected and assessed by histochemic
270 d 2 OCPs measured in banked second-trimester serum samples were compared between the diagnostic group
282 Clinical measurements were recorded; GCF and serum samples were obtained from each participant before
290 diagnostic sensitivity by only 2.2% (1 of 46 serum samples) when combined with the IgG anti-BP180 enz
291 ering light from any molecule present in the serum sample which can be also immobilised on the nanofi
292 rry out quantitative troponin I detection in serum samples with < 2microl sample volume in 5min.
293 ombining small RNA sequencing from 179 human serum samples with a neural network analysis produced a
294 bodies to multiple viral antigens in patient serum samples with detection limits for human IgG in the
297 or the detection of tetracycline in milk and serum samples with LODs of 740 and 710 pM, respectively.
298 OME in pharmaceutical formulation and human serum samples with mean recoveries of 100.97% and 98.58%
299 and sixty-three metabolites were measured in serum samples with the AbsoluteIDQ kit p150 (Biocrates)
300 ucose assays in standard solutions and human serum samples worked reproducibly with close to 100% rec
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。